Abstract:Objective To evaluate the peripheral dose (PD) from megavoltage cone-beam CT (MVCBCT) imaging for head-and-neck region image-guided radiation therapy, to determine the correlationof PD with monitor unit (MU), and to investigate the impact of imaging field size on the PD. MethodsMeasurements of PD from MVCBCT were made with a 0.65 cm3 ionization chamber placed in a specially designed phantom at various depths and distances from the field edges. The PD at reference point inside the phantom was measured with the same ionization chamber to investigate the linearity between MU used forMVCBCT and the PD. The homogeneity of PD in the axial plane of the phantom were measured. ResultsPD from MVCBCT increased with increasing number of MU used for imaging and with increasing the field size. The measured PD in the phantom decreased exponentially as distance from the field edges increased. PD also decreased as the depth from the phantom surface increased. There was a strong linear relationship between PD and MUs used for MVCBCT. The PD was heterogeneous, with higher dose at the anterior than the posterior. Conclusions The PD from MVCBCT depend much on the MVCBCT delivery MU and the scan field size. In clinic, using the smallest number of MU allowable and reducing MVCBCT scanning field size without compromising acquired image quality is an effective method of reducing the PD.
JIA Ming-xuan*,LIU Da-wei,ZHANG Xu et al. Measurements of the peripheral dose from megavoltage cone-beam CT imaging for head-and-neck region image-guided radiation therapy[J]. Chinese Journal of Radiation Oncology, 2013, 22(2): 151-153.
[1] Morin O, Gillis A, Xia P, et al. Patient dose considerations for routine megavoltage cone-beam CT imaging. Med Phys,2007,34:1819-1827. [2] Morin O, Chen J, Aubin M, et al. Dose calculation using Megavoltage cone-beam CT. Int J Radiat Oncol Biol Phys,2007,67:1201-1210. [3] Chen J, Morin O, Aubin M, et al. Dose-guided radiation therapy with megavoltage cone-beam CT. Br J Radiol,2006,79:87-98. [4] Morin O, Aubry JF, Hashemi AB, et al. Physical performance and image optimization of megavoltage cone-beam CT. Med Phys,2009,36:1421-1432. [5] Gayou O, Parda DS, Johnson M, et al. Patient dose and image quality from mega-voltage cone beam computed tomography imaging. Med Phys,2007,34:499-506. [6] Gayou O, Miften M. Commissioning and clinical implementation of a mega-voltage cone beam CT system foe treatment localization. Med Phys,2007,34:3183-3192. [7] Miften M, Gayou O, Reitz B, et al. IMRT planning and delivery incorporating daily dose from mega-voltage cone-beam computed tomography imaging. Med Phys,2007,34:3760-3767. [8] Peng LC, Yang CCJ, Sim S, et al. Dose comparison of megavoltage cone-beam and orthogonal-pair potal images. J Appl Clin Med Phys,2007,8:10-20. [9] Pouliot J, Bani-Hashemi A, Chen J, et al. Low-dose megavoltage cone-beam CT for radiation therapy. Int J Radiat Oncol Biol Phys,2005,61:552-560. [10] Islam MK, Purdie TG, Norrlinger BD, et al. Patient dose from kilovoltage cone beam computed tomography imaging in radiation therapy. Med Phys,2006,33:1573-1582. [11] Ding GX, Coffey CW. Radiation dose from kilovoltage cone beam computed tomography in an image-guided radiotherapy procedure. Int J Radiat Oncol Biol Phys,2009,73:610-617. [12] Kan MWK, Leung LHT, Wong W, et al. Radiation dose from cone beam computed tomography for image-guided radiation therapy. Int J Radiat Oncol Biol Phys,2008,70:272-279. [13] Perks JR, Lehmann J, Chen AM, et al. Comparison of peripheral dose from image-guided radiation therapy using kv cone beam CT to intensity-modulated radiation therapy. Radiother Oncol,2008,89:304-310. [14] Sharma SD, Upreti RR, Laskar S, et al. Estimation of risk of radiation-induced carcinogenesis in adolescents with nasopharyngeal cancer treated using sliding window IMRT. Radiother Oncol,2008,86:177-181. [15] Verellen D, Vanhavere F. Risk assessment of radiation-induced malignancies based on whole-body equivalent dose estimates for IMRT treatment in the head and neck region. Radiother Oncol,1999,53:199-203.